AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17034536 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 119
Study 17034536 — intervention group
Group type: EXPERIMENTAL
Intervention: Subject and investigator preferences
Number of subjects: 119
Study 17034536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosmetic outcome
Number of subjects: 119
Study 17034536 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin discomfort and adverse events
Number of subjects: 119
Study 14557158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention period with test charge information on emergency department records
Number of subjects: 3198
Study 14557158 — intervention group
Group type: COMPARATOR
Intervention: Control period for high test users
Number of subjects: 3198
Study 14557158 — intervention group
Group type: COMPARATOR
Intervention: Control period for low test users
Number of subjects: 3198
Study 14557158 — intervention group
Group type: EXPERIMENTAL
Intervention: Low test users vs high test users
Number of subjects: 3198
Study 10914048 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam premedication (oral, 1 hour before BMP)
Number of subjects: 16
Study 10914048 — intervention group
Group type: COMPARATOR
Intervention: Placebo premedication (oral, 1 hour before BMP)
Number of subjects: 16
Study 8623975 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 2.5 mg/h, PSA nalbuphine 1 mg
Number of subjects: 51
Study 8623975 — intervention group
Group type: COMPARATOR
Intervention: Naloxone 50 micrograms/hr, PSA saline
Number of subjects: 51
Study 8623975 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 50 micrograms/h, PSA naloxone 40 micrograms
Number of subjects: 51
Study 1564028 — intervention group
Group type: EXPERIMENTAL
Intervention: methylphenidate
Number of subjects: 7
Study 1564028 — intervention group
Group type: EXPERIMENTAL
Intervention: lithium carbonate alone
Number of subjects: 7
Study 1564028 — intervention group
Group type: EXPERIMENTAL
Intervention: methylphenidate and lithium carbonate in combination
Number of subjects: 7
Study 1564028 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7
Study 3935644 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelletized cromolyn (cromolyn sodium, 20 mg)
Number of subjects: 100
Study 3935644 — intervention group
Group type: COMPARATOR
Intervention: Cromolyn blend (cromolyn sodium, 20 mg + lactose, 20 mg)
Number of subjects: 100
Study 31707149 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 81 mg
Number of subjects: 49
Study 31707149 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 325 mg
Number of subjects: 49
Study 31707149 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole (40 mg) twice daily
Number of subjects: 49
Study 31707149 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) placebo
Number of subjects: 49
Study 28222577 — intervention group
Group type: EXPERIMENTAL
Intervention: SUPP: 500 mg alpha glycerophosphocholine [AGPC], 250 mg uridine‐5'‐monophosphate, and 1500 mg DHA
Number of subjects: 20
Study 28222577 — intervention group
Group type: COMPARATOR
Intervention: PLA (placebo)
Number of subjects: 20
Study 25785788 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy for depressed adolescents (IPT‐A)
Number of subjects: 32
Study 24481133 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice supplementation (0.5 l/day organic beetroot juice containing about 5.5 mmol of NO₃⁻)
Number of subjects: 14
Study 24481133 — intervention group
Group type: COMPARATOR
Intervention: Control swimming test (CSW)
Number of subjects: 14
Study 21978203 — intervention group
Group type: EXPERIMENTAL
Intervention: Numeracy skills at level 2 or above
Number of subjects: 112
Study 21978203 — intervention group
Group type: COMPARATOR
Intervention: Numeracy skills below level 2
Number of subjects: 112
Study 20353024 — intervention group
Group type: EXPERIMENTAL
Intervention: Jianpi Tiaogan Wenshen Recipe (JTWR)
Number of subjects: 80
Study 20353024 — intervention group
Group type: COMPARATOR
Intervention: Pinaverium bromide tablet (PVB)
Number of subjects: 80
Study 18959094 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics (particularly loop diuretics)
Number of subjects: 0
Study 18959094 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldosterone antagonists (spironolactone and eplerenone)
Number of subjects: 0
Study 18959094 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 0
Study 16087795 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF (10 microg/kg, subcutaneously applied for 14 days, total of 7 injections)
Number of subjects: 40
Study 16087795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 16087795 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF
Number of subjects: 40
Study 12483770 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhang and Boos extension of the standard CMH statistic
Number of subjects: 0
Study 12483770 — intervention group
Group type: COMPARATOR
Intervention: Standard CMH statistic
Number of subjects: 0
Study 12483770 — intervention group
Group type: COMPARATOR
Intervention: Bootstrap method
Number of subjects: 0
Study 12483770 — intervention group
Group type: COMPARATOR
Intervention: Method using design effect to reduce effective sample size
Number of subjects: 0
Study 10362041 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal spacer (Nebuchamber)
Number of subjects: 33
Study 10362041 — intervention group
Group type: COMPARATOR
Intervention: Plastic spacer (Babyhaler)
Number of subjects: 33
Study 10362041 — intervention group
Group type: COMPARATOR
Intervention: Plastic spacer (Volumatic)
Number of subjects: 33
Study 7742149 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 64
Study 7742149 — intervention group
Group type: COMPARATOR
Intervention: Renin inhibitor
Number of subjects: 64
Study 1836569 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin or cefotaxime (3 doses of 1 g administered 8-hourly)
Number of subjects: 1254
Study 1836569 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone (1 single dose of 1 g)
Number of subjects: 1254
Study 6112844 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 10
Study 6112844 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 10
Study 6112844 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10
Study 6112844 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta1-selective blockade
Number of subjects: 10
Study 6112844 — intervention group
Group type: COMPARATOR
Intervention: Beta-blockers (general)
Number of subjects: 10
Study 31155691 — intervention group
Group type: EXPERIMENTAL
Intervention: Crowdsourcing interventions
Number of subjects: 15
Study 28286985 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced respiration
Number of subjects: 5
Study 28286985 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 5
Study 28286985 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness interventions
Number of subjects: 5
Study 28286985 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis interventions
Number of subjects: 5
Study 28286985 — intervention group
Group type: EXPERIMENTAL
Intervention: Various relaxation interventions
Number of subjects: 5
Study 25323620 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity endurance and strength training (60 min, three times a week, for 20 weeks)
Number of subjects: 61
Study 25323620 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard postoperative care)
Number of subjects: 61
Study 23775366 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic fundoplication
Number of subjects: 357
Study 23775366 — intervention group
Group type: COMPARATOR
Intervention: Continued medical management
Number of subjects: 357
Study 21241214 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-dose nevirapine (ED-NVP)
Number of subjects: 43
Study 21241214 — intervention group
Group type: COMPARATOR
Intervention: Single-dose nevirapine (SD-NVP)
Number of subjects: 43
Study 19293532 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 163
Study 19293532 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma BH4 levels
Number of subjects: 163
Study 19293532 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma BH2 levels
Number of subjects: 163
Study 19293532 — intervention group
Group type: EXPERIMENTAL
Intervention: BH4/BH2 ratio
Number of subjects: 163
Study 16890682 — intervention group
Group type: EXPERIMENTAL
Intervention: Uriston (P. niruri extract) 2 gm daily for at least 3 months (group 1)
Number of subjects: 150
Study 16890682 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 2)
Number of subjects: 150
Study 14520089 — intervention group
Group type: EXPERIMENTAL
Intervention: No antibiotics for AOM
Number of subjects: 63
Study 14520089 — intervention group
Group type: COMPARATOR
Intervention: Placebo for recurrent AOM
Number of subjects: 63
Study 14520089 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment for OME after untreated AOM
Number of subjects: 63
Study 14520089 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment for OME of unknown duration
Number of subjects: 63
Study 14520089 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment for chronic OME
Number of subjects: 63
Study 10912758 — intervention group
Group type: EXPERIMENTAL
Intervention: Trp allele presence in white subjects
Number of subjects: 1394
Study 10912758 — intervention group
Group type: EXPERIMENTAL
Intervention: Trp allele presence in white subjects with multivariate adjustment
Number of subjects: 1394
Study 10912758 — intervention group
Group type: EXPERIMENTAL
Intervention: Trp allele presence in older white subjects with specific risk factors
Number of subjects: 1394
Study 10912758 — intervention group
Group type: COMPARATOR
Intervention: Trp allele presence in black subjects
Number of subjects: 1394
Study 10912758 — intervention group
Group type: EXPERIMENTAL
Intervention: Trp allele presence in black subjects with multivariate adjustment
Number of subjects: 1394
Study 9130746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubal embryo transfer
Number of subjects: 138
Study 9130746 — intervention group
Group type: COMPARATOR
Intervention: Uterine transfer
Number of subjects: 138
Study 9130746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (tubal and uterine transfer)
Number of subjects: 138
Study 8406967 — intervention group
Group type: EXPERIMENTAL
Intervention: Post space prepared immediately after canal obturation
Number of subjects: 72
Study 8406967 — intervention group
Group type: EXPERIMENTAL
Intervention: Post space prepared after 1 week of storage in 100% relative humidity at 37 degrees C
Number of subjects: 72
Study 8406967 — intervention group
Group type: COMPARATOR
Intervention: Control group (no post space preparation)
Number of subjects: 72
Study 8406967 — intervention group
Group type: EXPERIMENTAL
Intervention: Post space preparation (both intervention groups)
Number of subjects: 72
Study 3534902 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 X 60 mg Eburnamonine per day (n = 25)
Number of subjects: 99
Study 3534902 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 X 60 mg Eburnamonine per day (n = 25)
Number of subjects: 99
Study 3534902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 30501388 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotator cuff strengthening plus coactivation with pectoralis major and latissimus dorsi recruitment
Number of subjects: 42
Study 30501388 — intervention group
Group type: COMPARATOR
Intervention: Strengthening of the scapular and rotator cuff muscles
Number of subjects: 42
Study 29781943 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterilized in autoclave (40 rods)
Number of subjects: 44
Study 29781943 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterilized using hydrogen peroxide (40 rods)
Number of subjects: 44
Study 29781943 — intervention group
Group type: COMPARATOR
Intervention: Unsterilized (4 rods)
Number of subjects: 44
Study 27376867 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention consisting of an e‐alert, care bundle and education programme
Number of subjects: 0
Study 24761922 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation of faecal occult blood test (FOBT)
Number of subjects: 116
Study 24761922 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to colorectal cancer screening
Number of subjects: 116
Study 21479957 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cadence interval training (Int(60), 60 rev min(‐1))
Number of subjects: 18
Study 21479957 — intervention group
Group type: EXPERIMENTAL
Intervention: High-cadence interval training (Int(100), 100 rev min(‐1))
Number of subjects: 18
Study 21479957 — intervention group
Group type: COMPARATOR
Intervention: Control group (Con)
Number of subjects: 18
Study 20383685 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive self‐assisted range of motion exercise associated with continuous passive motion (CPM) for 2 hours per day for 4 weeks
Number of subjects: 100
Study 20383685 — intervention group
Group type: COMPARATOR
Intervention: Passive self‐assisted range of motion exercise alone
Number of subjects: 100
Study 18846701 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol (2.5 g/d)
Number of subjects: 54
Study 18846701 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol (2.5 g/d)
Number of subjects: 54
Study 18846701 — intervention group
Group type: COMPARATOR
Intervention: Control margarine (no added plant sterols or stanols)
Number of subjects: 54
Study 15914133 — intervention group
Group type: EXPERIMENTAL
Intervention: Three gels containing different amounts of N-9 per dose
Number of subjects: 1536
Study 15914133 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppository
Number of subjects: 1536
Study 15914133 — intervention group
Group type: EXPERIMENTAL
Intervention: Film
Number of subjects: 1536
Study 15914133 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall acceptability of all five spermicides
Number of subjects: 1536
Study 15914133 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall acceptability
Number of subjects: 1536
Study 12191837 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g of glucose administered immediately before presentation of a word list
Number of subjects: 0
Study 12191837 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g of glucose administered immediately after presentation of a word list
Number of subjects: 0
Study 12191837 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g of glucose administered 15 min before learning the word list
Number of subjects: 0
Study 12191837 — intervention group
Group type: COMPARATOR
Intervention: Aspartame solution (control)
Number of subjects: 0
Study 11904624 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose on a pacifier
Number of subjects: 0
Study 11904624 — intervention group
Group type: EXPERIMENTAL
Intervention: Mogen procedure
Number of subjects: 0
Study 11904624 — intervention group
Group type: COMPARATOR
Intervention: Gomco procedure
Number of subjects: 0
Study 9531185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.01 microg/kg/min)
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.05 microg/kg/min)
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.1 microg/kg/min)
Number of subjects: 247
Study 9531185 — intervention group
Group type: COMPARATOR
Intervention: Placebo (diabetic patients)
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.01 microg/kg/min) (diabetic patients)
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.05 microg/kg/min) (diabetic patients)
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.1 microg/kg/min) (diabetic patients)
Number of subjects: 247
Study 9531185 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nondiabetic patients)
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.01 microg/kg/min) (nondiabetic patients)
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.05 microg/kg/min) (nondiabetic patients)
Number of subjects: 247
Study 9531185 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaritide (0.1 microg/kg/min) (nondiabetic patients)
Number of subjects: 247
Study 7979152 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte aggregation in patients with hemorrhoidal disease
Number of subjects: 62
Study 7979152 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 62
Study 7979152 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with acute hemorrhoid problems
Number of subjects: 62
Study 2567265 — intervention group
Group type: EXPERIMENTAL
Intervention: SKF 94482 200 mg at 07:30
Number of subjects: 16
Study 2567265 — intervention group
Group type: EXPERIMENTAL
Intervention: SKF 94482 200 mg at 17:30
Number of subjects: 16
Study 2567265 — intervention group
Group type: EXPERIMENTAL
Intervention: SKF 94482 200 mg at 21:30
Number of subjects: 16
Study 2567265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30776909 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron isomaltoside
Number of subjects: 40
Study 28718527 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional Verapamil (10 mg in 5 mL of normal saline water) weekly for 12 weeks
Number of subjects: 0
Study 28718527 — intervention group
Group type: COMPARATOR
Intervention: Intralesional Hyaluronic Acid (0.8% highly purified sodium salt HA 16 mg/2 mL) weekly for 12 weeks
Number of subjects: 0
Study 25444633 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated biofeedback and pelvic floor muscle (PFM) exercise
Number of subjects: 50
Study 25444633 — intervention group
Group type: COMPARATOR
Intervention: Standard urotherapy
Number of subjects: 50
Study 24262620 — intervention group
Group type: EXPERIMENTAL
Intervention: ANGIOGUARD
Number of subjects: 60
Study 24262620 — intervention group
Group type: COMPARATOR
Intervention: Mo.Ma
Number of subjects: 60
Study 21844178 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telehealth service using a web portal for videoconferencing and electronic messaging; duration: 9 months
Number of subjects: 99
Study 21844178 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 99
Study 18924040 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh techniques
Number of subjects: 1513008
Study 18924040 — intervention group
Group type: COMPARATOR
Intervention: Non-mesh techniques
Number of subjects: 1513008
Study 16820037 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanocrystalline hydroxyapatite (NHA)
Number of subjects: 22
Study 16820037 — intervention group
Group type: COMPARATOR
Intervention: Bovine-derived xenograft (BDX) in combination with collagen membrane (BG)
Number of subjects: 22
Study 14559891 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant 375 mg before cisplatin and 250 mg on days 2 to 5 (n = 35)
Number of subjects: 202
Study 14559891 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant 125 mg before cisplatin and 80 mg on days 2 to 5 (n = 81)
Number of subjects: 202
Study 14559891 — intervention group
Group type: COMPARATOR
Intervention: Placebo before cisplatin on days 2 to 5 (n = 86)
Number of subjects: 202
Study 10840297 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (10-day proton pump inhibitor-based triple therapy)
Number of subjects: 301
Study 10840297 — intervention group
Group type: COMPARATOR
Intervention: Dual antibiotic therapy
Number of subjects: 301
Study 10840297 — intervention group
Group type: EXPERIMENTAL
Intervention: Antral histology
Number of subjects: 301
Study 10840297 — intervention group
Group type: EXPERIMENTAL
Intervention: Antral culture
Number of subjects: 301
Study 10840297 — intervention group
Group type: EXPERIMENTAL
Intervention: Antral biopsies without body biopsies
Number of subjects: 301
Study 10840297 — intervention group
Group type: EXPERIMENTAL
Intervention: Histologic examination of antral biopsies
Number of subjects: 301
Study 9166175 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg daily)
Number of subjects: 19
Study 9166175 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 19
Study 8466096 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine, 10 mg, once daily (QD)
Number of subjects: 160
Study 8466096 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine, 60 mg, twice daily (BID)
Number of subjects: 160
Study 31801388 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone acetate (10mg/ml)
Number of subjects: 60
Study 31801388 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac (1mg/ml)
Number of subjects: 60
Study 31801388 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (prednisolone acetate and nepafenac)
Number of subjects: 60
Study 31113830 — intervention group
Group type: EXPERIMENTAL
Intervention: HTX-011
Number of subjects: 412
Study 31113830 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine HCl
Number of subjects: 412
Study 31113830 — intervention group
Group type: COMPARATOR
Intervention: saline placebo
Number of subjects: 412
Study 28348183 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant+ app and standard care
Number of subjects: 230
Study 28348183 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 230
Study 26307570 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 1.7 g
Number of subjects: 45
Study 26307570 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 3.4 g
Number of subjects: 45
Study 26307570 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 6.8 g
Number of subjects: 45
Study 26307570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 26307570 — intervention group
Group type: EXPERIMENTAL
Intervention: CSL112 (all doses)
Number of subjects: 45
Study 24261057 — intervention group
Group type: COMPARATOR
Intervention: Endurance Training Program (ETP)
Number of subjects: 29
Study 24261057 — intervention group
Group type: COMPARATOR
Intervention: Coordination Training Program (CTP)
Number of subjects: 29
Study 20870337 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity cognitive therapy with nicotine replacement therapy (NRT)
Number of subjects: 1843